Literature DB >> 31233323

Baseline cocaine demand predicts contingency management treatment outcomes for cocaine-use disorder.

Jin H Yoon1, Robert Suchting1, Sarah A McKay1, Guadalupe G San Miguel1, Anka A Vujanovic2, Angela L Stotts3, Scott D Lane1, Jessica N Vincent1, Michael F Weaver1, Austin Lin1, Joy M Schmitz1.   

Abstract

Cocaine use disorder (CUD) is a significant public health issue. Behavioral interventions such as contingency management (CM) have been demonstrated to be highly effective in promoting cocaine abstinence. However, identifying individual characteristics associated with cocaine relapse may help improve treatment outcomes. Cocaine demand is a behavioral economic measure that shares a scientific foundation with CM. In the current study, we assessed baseline cocaine demand using a hypothetical cocaine purchasing task. Participants (N = 58) consisted of treatment-seeking individuals with CUD. All participants received 1 month of CM treatment for cocaine abstinence, and treatment responders were defined as presenting 6 consecutive cocaine negative urine samples from thrice weekly clinic visits. Demand data were well described by the exponentiated demand model. Indices of demand (intensity of demand [Q₀], elasticity [α]) were significantly associated with recent (last 30 days) cocaine use. Importantly, linear regression revealed that CM treatment nonresponders presented significantly higher Q₀ (p = .025). Subsequent quantile regression analyses examining the relationship between CM treatment response and Q₀ revealed statistically reliable effects of being a nonresponder across 3 of the lower percentiles (i.e., 15, 25, and 30). Overall, these findings provide further support for the utility of exponentiated demand model. To our knowledge, this is the first study to demonstrate an association between baseline demand and contingency management response and systematically extend the findings of prior demand research to a novel drug class, cocaine. (PsycINFO Database Record (c) 2020 APA, all rights reserved).

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31233323      PMCID: PMC6928450          DOI: 10.1037/adb0000475

Source DB:  PubMed          Journal:  Psychol Addict Behav        ISSN: 0893-164X


  60 in total

Review 1.  Neuropsychiatric effects of cocaine use disorders.

Authors:  Charles U Nnadi; Olubansile A Mimiko; Henry L McCurtis; Jean Lud Cadet
Journal:  J Natl Med Assoc       Date:  2005-11       Impact factor: 1.798

2.  Further validation of a cigarette purchase task for assessing the relative reinforcing efficacy of nicotine in college smokers.

Authors:  James MacKillop; James G Murphy; Lara A Ray; Daniel T A Eisenberg; Stephen A Lisman; J Koji Lum; David S Wilson
Journal:  Exp Clin Psychopharmacol       Date:  2008-02       Impact factor: 3.157

Review 3.  Follow-up of infants prenatally exposed to cocaine.

Authors:  Cassandra Schiller; Pat Jackson Allen
Journal:  Pediatr Nurs       Date:  2005 Sep-Oct

4.  Initial evidence for the reliability and validity of a "Lite" version of the Addiction Severity Index.

Authors:  John S Cacciola; Arthur I Alterman; A Thomas McLellan; Yi-Ting Lin; Kevin G Lynch
Journal:  Drug Alcohol Depend       Date:  2006-10-11       Impact factor: 4.492

Review 5.  Cocaine cardiovascular toxicity.

Authors:  Steven B Karch
Journal:  South Med J       Date:  2005-08       Impact factor: 0.954

6.  Effects of increasing income on polydrug use: a comparison of heroin, cocaine and alcohol abusers.

Authors:  N M Petry
Journal:  Addiction       Date:  2000-05       Impact factor: 6.526

7.  Cigarette demand and delayed reward discounting in nicotine-dependent individuals with schizophrenia and controls: an initial study.

Authors:  James MacKillop; Jennifer W Tidey
Journal:  Psychopharmacology (Berl)       Date:  2011-02-16       Impact factor: 4.530

8.  A two-phased screening paradigm for evaluating candidate medications for cocaine cessation or relapse prevention: modafinil, levodopa-carbidopa, naltrexone.

Authors:  Joy M Schmitz; Charles E Green; Angela L Stotts; Jan A Lindsay; Nuvan S Rathnayaka; John Grabowski; F Gerard Moeller
Journal:  Drug Alcohol Depend       Date:  2014-01-03       Impact factor: 4.492

9.  A behavioral economic analysis of the nonmedical use of prescription drugs among young adults.

Authors:  Alison M Pickover; Bryan G Messina; Christopher J Correia; Kimberly B Garza; James G Murphy
Journal:  Exp Clin Psychopharmacol       Date:  2016-02       Impact factor: 3.157

10.  Medical staff contributions to thirdhand smoke contamination in a neonatal intensive care unit.

Authors:  Thomas F Northrup; Angela L Stotts; Robert Suchting; Amir M Khan; Charles Green; Penelope J E Quintana; Eunha Hoh; Melbourne F Hovell; Georg E Matt
Journal:  Tob Induc Dis       Date:  2019-04-24       Impact factor: 2.600

View more
  4 in total

1.  Time Cost and Demand: Implications for Public Policy.

Authors:  Lindsay P Schwartz; Steven R Hursh
Journal:  Perspect Behav Sci       Date:  2022-07-06

2.  Mile high on heroin: Lessons on the opioid epidemic from the Mile High City.

Authors:  Jamie Peters
Journal:  Bioessays       Date:  2022-03-31       Impact factor: 4.653

3.  Initial development of a brief assessment of cocaine demand.

Authors:  Jin H Yoon; Constanza de Dios; Robert Suchting; Jessica N Vincent; Sarah A McKay; Scott D Lane; Joy M Schmitz
Journal:  Behav Pharmacol       Date:  2021-06-01       Impact factor: 2.277

4.  Assessment of demand for methamphetamine and cigarettes among individuals with methamphetamine use disorder.

Authors:  Jin H Yoon; Robert Suchting; Rachel N Cassidy; Peter K Bolin; Yasmine Omar; Gregory S Brown; Richard De La Garza
Journal:  Exp Clin Psychopharmacol       Date:  2020-03-23       Impact factor: 3.492

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.